DAIC Articles

May 30, 2017 | DAIC Articles
Ra Medical Systems Receives FDA Clearance for New Peripheral Artery Disease Treatment

“The U.S. Food and Drug Administration (FDA) announced that it has granted market clearance to Ra Medical Systems for the company’s DABRA (Destruction of Ateriosclerotic Blockages by laser Radiation Ablation) System.”

May 30, 2017 | DAIC Articles
FFR-Search Registry Reveals Impact of Post-PCI Fraction Flow Reserve Measurement on Outcomes

“Early results from the independent, physician-sponsored FFR-Search Registry revealed an association between post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) measurements with the Acist Navvus Rapid Exchange FFR MicroCatheter and clinical outcomes. The results reveal a potential new role for FFR in cath labs.”

May 30, 2017 | DAIC Articles
Positive European Registry Results For Watchman Left Atrial Appendage Closure Device

“Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry presented during a late-breaking clinical trial session at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.”

May 30, 2017 | DAIC Articles
Canadian Cardiologist Publishes World-First Mitral Regurgitation Procedure

“A Canadian cardiologist has published a report in the journal Eurointervention describing how he used a Canadian-invented device for the first time in the world to successfully insert a MitraClip through a patient’s jugular vein rather than the femoral vein.”

May 26, 2017 | DAIC Articles
Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients

“Recent outcomes from the MAVERIC clinical trial confirm earlier positive findings that MVRx’s Arto System safely and effectively treats mitral valve regurgitation associated with congestive heart failure.”

May 25, 2017 | DAIC Articles
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery

“A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day reduction in ICU stay and a $3,654 reduction in per-patient hospitalization costs for coronary artery bypass graft (CABG) surgery.”

May 25, 2017 | DAIC Articles
Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial

“Positive results from the REPRISE III clinical trial, presented at the annual EuroPCR Scientific Program, in Paris, demonstrated that the Boston Scientific Lotus Valve System, a transcatheter aortic valve implantation (TAVI) system, showed superiority over the Medtronic CoreValve TAVR System platform for the primary effectiveness endpoint and non-inferiority for the primary safety endpoint.”

May 24, 2017 | DAIC Articles
Edwards’ Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes

“Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for transcatheter aortic valve replacement (TAVR) patients treated with the new self-expanding Edwards Lifesciences’ Centera valve. These new 30-day results are the first data presented on the self-expanding Edwards Centera valve.”

May 24, 2017 | DAIC Articles
3-D Echo Image Analysis With Philips’ HeartModel A.I. is Accurate and Reproducible

“Philips recently announced the results from a global study indicating that automated three-dimensional echocardiographic (3DE) analysis of left-heart chambers is an accurate alternative to conventional manual methodology.”

May 23, 2017 | DAIC Articles
Home Monitoring Reduces All-Cause Mortality in ICD Patients

“Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of all-cause mortality in ICD patients after one year by 38 percent.”